NCPI Workmark
Articles in regional publications that pertain to a wide range of North Carolina-related topics.

Search Results


5 results for "University of North Carolina at Chapel Hill. Department of Neurology"
Currently viewing results 1 - 5
PAGE OF 1
Record #:
25821
Author(s):
Abstract:
Neurologists have been studying brain tumor cells to learn how they respond to chemotherapy and a molecule called Cytochrome C. Scientists tested several different cell types from brain tumors and found that all were sensitive to the chromosome, and many of the tumor cells were killed.
Source:
Endeavors (NoCar LD 3941.3 A3), Vol. 24 Issue 3, Spring 2008, p34-36, il, por Periodical Website
Full Text:
Record #:
25822
Author(s):
Abstract:
Fulton Crews’ research on binge drinking shows how brain damage that impairs decision-making can occur long after the drinking stops. Binge drinking can cause loss of neurons and changes in the brain structure, leading to repeated behaviors and difficulty relearning.
Source:
Full Text:
Record #:
17041
Author(s):
Abstract:
University of North Carolina's expanding Department of Neurology led by Dr. Frank Longo, targets stroke, Alzheimer's, epilepsy, and sleep disorders.
Source:
Metro Magazine (NoCar F 264 R1 M48), Vol. 4 Issue 2, Mar 2003, p19-22, 25, f Periodical Website
Full Text:
Record #:
26073
Author(s):
Abstract:
The Neurosciences Research Center has recruited scientists from a variety of fields to figure out how to make a brain. Some of their research investigates basic brain structures, nerve cell regeneration and development, and brain proteins. By understanding the brain as a whole, scientists hope to make progress in treating neurological disorders.
Source:
Endeavors (NoCar LD 3941.3 A3), Vol. 18 Issue 3, Spring 2002, p7-13, il, por Periodical Website
Full Text:
Record #:
26074
Author(s):
Abstract:
Richard Mailman is a professor of psychiatry, pharmacology, and medicinal chemistry. His research has focused on dopamine receptors and their potential as treatment for Parkinson’s disease. Mailman’s lab is currently studying drug tolerance of dopamine receptors.
Source:
Endeavors (NoCar LD 3941.3 A3), Vol. 18 Issue 3, Spring 2002, p14-17, il, por Periodical Website
Full Text: